Brain tumours in children have a devastating impact through the years of life lost and life-altering disability. Pathology is the principal step in determining their outcomes because it is the major determinant of treatments that define the likelihood of survival and damage to the developing brain.
Also of interest
-
Current advances and issues in the diagnosis and management of primary immune deficiencies in children
Elizabeth Ralph of Great Ormond Street Hospital for Children reports on paediatric immune deficiencies.